ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall Fields sold 3,000 shares of the company's stock in a transaction on Monday, September 22nd. The stock was sold at an average price of $17.58, for a total value of $52,740.00. Following the sale, the chief executive officer owned 69,000 shares of the company's stock, valued at approximately $1,213,020. This represents a 4.17% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
ReposiTrak Stock Performance
TRAK stock traded down $0.30 during midday trading on Tuesday, reaching $17.15. The stock had a trading volume of 48,283 shares, compared to its average volume of 50,697. The firm has a market cap of $313.50 million, a PE ratio of 50.44 and a beta of 0.47. The company has a current ratio of 6.03, a quick ratio of 6.03 and a debt-to-equity ratio of 0.01. The firm has a fifty day simple moving average of $17.02. ReposiTrak Inc. has a 52-week low of $15.12 and a 52-week high of $25.01.
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets increased its stake in ReposiTrak by 63.5% during the 2nd quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company's stock worth $32,000 after buying an additional 634 shares during the period. Tower Research Capital LLC TRC lifted its stake in shares of ReposiTrak by 397.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company's stock worth $71,000 after acquiring an additional 2,892 shares during the period. R Squared Ltd acquired a new stake in shares of ReposiTrak during the second quarter valued at approximately $235,000. Rhumbline Advisers increased its stake in ReposiTrak by 69.1% in the 2nd quarter. Rhumbline Advisers now owns 18,036 shares of the company's stock valued at $354,000 after buying an additional 7,371 shares during the period. Finally, Coldstream Capital Management Inc. grew its position in ReposiTrak by 47,619.0% in the second quarter. Coldstream Capital Management Inc. now owns 20,042 shares of the company's stock worth $394,000 after acquiring an additional 20,000 shares in the last quarter. 27.35% of the stock is owned by hedge funds and other institutional investors.
About ReposiTrak
(
Get Free Report)
Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ReposiTrak, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.
While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.